Evidence map›Paper›PMID 26157322›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2015

Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China.

Xuelong Jiao, Yujun Li, Hongyan Wang, Shanglong Liu, Dongfeng Zhang, Yanbing Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuelong Jiao1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.
Yujun Li1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.
Hongyan Wang1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.
Shanglong Liu1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.
Dongfeng Zhang1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.
Yanbing Zhou1 General Surgery Department, 2 Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao 266003, China ; 3 Department of Epidemiology and Health Statistics, The Medical College of Qingdao University, Qingdao 266003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the clinicopathological features, survival and prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) in a Chinese population.

methodsWe investigated 154 consecutive patients (88 males, 66 females; median age 56 years, age range 9-86 years) diagnosed with GEP-NENs between 2001 and 2013 at The Affiliated Hospital of Qingdao University. Demographic, clinical and pathological variables and survival data were retrieved.

resultsThe pancreas was the most common site of involvement (63/154, 40.9%). Tumor size varied from 0.3 to 16.0 cm (median, 1.2 cm). The patients were followed up for a median period of 22 months (range, 1-157 months). The estimated 3- and 5-year overall survival (OS) rates for all patients were 84.0% and 81.9%, respectively. Multivariate analysis showed that larger tumor size, lymphatic metastases and distant metastases were significant predictors for poor survival outcome.

conclusionsOur data provide further information on the clinicopathological features of GEP-NENs in China. Additionally, we identified tumor size, lymphatic metastases and distant metastases as independent prognostic factors for long-term survival.

Indexed as

clinicopathological characteristicsGastroenteropancreatic neuroendocrine neoplasm (GEP-NEN)Ki-67retrospective studysurvival analysis

Identifiers

PMID26157322
PMCPMC4490193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.